Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan

Author:

Saito NorihiroORCID,Kitazawa Junichi,Horiuchi Hiroko,Yamamoto Takeo,Kimura Masahiko,Inoue Fumio,Matsui Mika,Minakawa Satoko,Itoga Masamichi,Tsuchiya Junichiro,Suzuki Satowa,Hisatsune Junzo,Gu Yoshiaki,Sugai Motoyuki,Kayaba Hiroyuki

Abstract

Abstract Background Spread of vancomycin-resistant Enterococcus (VRE) is a global concern as a significant cause of healthcare-associated infections. A series of VRE faecium (VREf) outbreaks caused by clonal propagation due to interhospital transmission occurred in six general hospitals in Aomori prefecture, Japan. Methods The number of patients with VREf was obtained from thirty seven hospitals participating in the local network of Aomori prefecture. Thirteen hospitals performed active screening tests for VRE. Whole genome sequencing analysis was performed. Results The total number of cases with VREf amounted to 500 in fourteen hospitals in Aomori from Jan 2018 to April 2021. It took more than three years for the frequency of detection of VRE to return to pre-outbreak levels. The duration and size of outbreaks differed between hospitals according to the countermeasures available at each hospital. Whole genome sequencing analysis indicated vanA-type VREf ST1421 for most samples from six hospitals. Conclusions This was the first multi-jurisdictional outbreak of VREf sequence type 1421 in Japan. In addition to strict infection control measures, continuous monitoring of VRE detection in local medical regions and smooth and immediate communication among hospitals are required to prevent VREf outbreaks.

Funder

Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health

Reference38 articles.

1. Centers for Disease Control and Prevention. Biggest threats and data. https://www.cdc.gov/drugresistance/biggest-threats.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fbiggest_threats.html (accessed March 24 2021)

2. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13:686–707. https://doi.org/10.1128/CMR.13.4.686.

3. European Centre for Disease Prevention and Control (ECDC). Surveillance of antimicrobial resistance in Europe, 2020. Surveillance report 18 Nov 2021.

4. Hoshuyama T, Moriguchi H, Muratani T, et al. Vancomycin-resistant enterococci outbreak at a university hospital in Kitakyushu, Japan: case-control studies. J Infect Chemother. 2008;14:354–60. https://doi.org/10.1007/s10156-008-0628-x.

5. Japan nosocomial infections surveillance Sankairyousisetu Ichiran (in Japanese). https://janis.mhlw.go.jp/hospitallist/index.html (Accessed March 26 2021)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3